Affinity Asset Advisors’s Karyopharm Therapeutics KPTI Stock Holding History

Affinity Asset Advisors’s Portfolio KPTI Stock Details KPTI Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.55M	Buy
2025 Q3	–	Hold
2025 Q2	–	Hold
2023 Q2	–	Sell
2023 Q1	$1.79M	Sell
2022 Q4	$2.25M	Buy